Visalytics
Visalytics
approved EB-2 (NIW)

Senior QA Specialist

Pharmaceutical Sciences · India · 2024-01-30

Processing Time
5 days
Decision Date
2024-01-30
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research on using a quality-by-design approach to methodically design and develop investigational or shortened new drugs. This work focuses on improving drug development processes to make life-saving medicines safer, more ethical, accessible, and affordable within the U.S. healthcare system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research into quality-by-design for drug development addresses clinical and ethical challenges in the U.S. healthcare system.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to his 10 publications, 2 patents, and 15 citations demonstrating reliance by peers in the field.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to drug safety and affordability make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the applicant's record of 10 peer-reviewed journal articles, 2 granted patents, and 3 patent applications. His work garnered 15 citations on Google Scholar and demonstrated significant impact in the pharmaceutical field, satisfying the Dhanasar framework for a National Interest Waiver.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Government Alignment
Original Contributions

Similar Cases

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.
View Case

Postdoctoral Researcher

Chemicals · India

WeGreened EB-2 (NIW) approved
Massachusetts 156 days 2022-10-04
The petitioner proposes to continue research on developing state-of-the-art drug delivery approaches that cross biological interfaces. This work focuses on enabling the facile treatment of a wide range of disorders, including neurological disorders, metastatic cancer, and COVID-19, through protein-based therapies.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Others

Pharmaceuticals · Iran

WeGreened EB-2 (NIW) approved
598 days 2025-09-08
The petitioner proposes to advance drug discovery by designing and improving in-vitro testing methodologies to enhance precision and streamline timelines in pre-clinical research. Her work focuses on creating standardized approaches for toxin assessment to reduce the reliance on animal testing and lower the high failure rates of clinical trials.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-01-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 5 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist